“Prognostic value of KRAS G12C in advanced non-small cell lung cancer with high PD-L1 expression treated with upfront immunotherapy: a systematic review and meta-analysis”, Swiss Med Wkly, vol. 154, no. 7, p. 3695, Jul. 2024, doi: 10.57187/s.3695.